Can be used for maintenance when compliance is a problem. |
AMBER Flupentixol decanoate |
injection 20mg/ml, 1mL, 2mL |
concentrate injection 100mg/ml, 0.5mL, 1mL |
AMBER Fluphenazine decanoate |
injection 25mg/ml, 0.5ml amp, |
AMBER Haloperidol decanoate injection 100mg/mL |
AMBER Pipotiazine palmitate injection 50mg/ml |
AMBER Zuclopenthixol decanoate injection 200mg/ml, 500mg/ml |
|
Risperdal Consta® |
Risperdal Consta® restricted use – request from doctor must be sent to chief pharmacist and medical director of Lancashire Care Trust |
before authorised to prescribe |
RED Risperidone (Risperdal Consta®) injection |
25mg, 37.5mg. 50mg |
|
Abilify Maintena®, Xeplion® |
Aripiprazole prolonged-release (PR) suspension for injection and Paliperidone palmitate (PR) suspension for injection are |
recommended as treatment options in the maintenance treatment of schizophrenia in adult patients stabilised with oral |
aripiprazole where both of the following criteria are met; |
|
> where treatment is in line with the recommendations within NICE CG178 for the use of depot or long-acting injectable |
antipsychotic medication and |
> where treatment is in line with the Lancashire Care Guidance for Prescribing Second Generation Long Acting |
Antipsychotic Injections |
|
RED Aripiprazole (Abilify Maintena®) prolonged release suspension for injection, 400mg powder and solvent |
RED *Paliperidone (Xeplion®) prolonged release suspension for injection, 50mg, 75mg,100mg,150mg |
|
Paliperidone palmitate prolonged release suspension for injection (six monthly) |
Paliperidone palmitate 6-monthly injection is recommended as a treatment option for the maintenance treatment of |
schizophrenia in adult patients who are clinically stable on 1-monthly or 3-monthly paliperidone palmitate injectable products: |
> where treatment is in line with the recommendations within NICE CG178 for the use of depot or long-acting injectable |
antipsychotic medications, and |
> where treatment is in line with the Lancashire Care Guidance for Prescribing Second Generation Long Acting Antipsychotic |
injections |
RED Paliperidone palmitate prolonged release suspension for injection (six monthly) (Byannli) |
|
|
*MHRA Drug Safety Alert - Risperidone and paliperidone: risk of intraoperative floppy iris syndrome in patients undergoing cataract surgery |
All material in this section is aimed at health care professionals, but is information currently held in the public domain, members of the public seeking advice on medicine-related matters are advised to speak with their GP, pharmacist, nurse or contact NHS111 Service |
Email: info.elmmb@nhs.net |
|
Copyright© 2016 East Lancashire Medicines Management Board. |
All rights reserved. Disclaimer/Terms and conditions |
|
|
|
|
|
|
|
|
|
|